Cándido D. R.
- Country
- Spain
- Department
- Servicio de Nefrologia
Research Overview
- Phase 1 Evaluation of VIS171 Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity in Autoimmune Conditions: Alopecia Areata, Systemic Lupus Erythematosus, and Immune-Mediated Focal Segmental Glomerulosclerosis
- Phase I/IIa Multicenter Study of TranspoCART19 CD19 CAR‑T Cell Therapy in Patients with Refractory Lupus Nephritis: Safety and Preliminary Efficacy
- Phase 3 Randomized Double-Blind Placebo-Controlled Trial of Povetacicept in Adults with Immunoglobulin A Nephropathy
Data & Insights
Has run more than one trial at 42 of 266 partner sites.
Specializations
Renal Disorders
The investigator specializes in treating complex renal conditions, with particular focus on IgA Nephropathy and its various manifestations. Their research extends to innovative therapeutic approaches for managing proteinuria and preserving renal function.
- IgA Nephropathy Management
- Proteinuria Treatment
- Renal Function Preservation
Their expertise includes evaluating novel treatments for chronic kidney conditions.
Cardiovascular Medicine
The investigator focuses on atherosclerotic cardiovascular disease specifically in patients with end-stage kidney disease (ESKD). Their work encompasses the relationship between cardiovascular complications and dialysis treatments.
- ESKD Management
- Cardiovascular Disease in Dialysis Patients
- Inflammatory Biomarker Studies
Their research addresses cardiovascular outcomes in patients undergoing maintenance dialysis.
Rare Disease Research
The investigator has developed expertise in treating rare conditions such as atypical Hemolytic Uremic Syndrome (aHUS). Their work involves evaluating innovative therapeutic approaches for managing rare renal disorders.
- aHUS Treatment
- TMA Management
- Novel Therapeutic Approaches
Their research includes investigation of targeted treatments for rare kidney diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.